{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:11:06Z","timestamp":1761340266092,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7759\/cureus.91555","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T22:05:06Z","timestamp":1756937106000},"source":"Crossref","is-referenced-by-count":1,"title":["Idiosyncratic Drug-Induced Neutropenia Following Pantoprazole, Moxifloxacin Hydrochloride, and Rifabutin Treatment for Helicobacter pylori: A Case Report"],"prefix":"10.7759","author":[{"given":"Emily","family":"Furar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymara","family":"Fernandez de la Vara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061808","article-title":"Idiosyncratic drug-induced neutropenia and agranulocytosis in elderly patients","volume":"9","author":"Lorenzo-Villalba N","year":"2020","unstructured":"Lorenzo-Villalba N, Alonso-Ortiz MB, Maouche Y, Zulfiqar AA, Andr\u00e8s E. Idiosyncratic drug-induced neutropenia and agranulocytosis in elderly patients. J Clin Med. 2020, 9:1808. 10.3390\/jcm9061808","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.187","article-title":"Non-chemotherapy drug-induced neutropenia: key points to manage the challenges","volume":"2017","author":"Curtis BR","year":"2017","unstructured":"Curtis BR. Non-chemotherapy drug-induced neutropenia: key points to manage the challenges. Hematology Am Soc Hematol Educ Program. 2017, 2017:187-93. 10.1182\/asheducation-2017.1.187","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4MIR0220-574RR","article-title":"Neutrophils at the crossroads of innate and adaptive immunity","volume":"108","author":"Rosales C","year":"2020","unstructured":"Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. J Leukoc Biol. 2020, 108:377-96. 10.1002\/JLB.4MIR0220-574RR","journal-title":"J Leukoc Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcw220","article-title":"Idiosyncratic drug-induced neutropenia & agranulocytosis","volume":"110","author":"Andr\u00e8s E","year":"2017","unstructured":"Andr\u00e8s E, Mourot-Cottet R, Maloisel F, et al.. Idiosyncratic drug-induced neutropenia & agranulocytosis. QJM. 2017, 110:299-305. 10.1093\/qjmed\/hcw220","journal-title":"QJM"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-052120-014115","article-title":"HLA allele-restricted immune-mediated adverse drug reactions: framework for genetic prediction","volume":"62","author":"Jaruthamsophon K","year":"2022","unstructured":"Jaruthamsophon K, Thomson PJ, Sukasem C, Naisbitt DJ, Pirmohamed M. HLA allele-restricted immune-mediated adverse drug reactions: framework for genetic prediction. Annu Rev Pharmacol Toxicol. 2022, 62:509-29. 10.1146\/annurev-pharmtox-052120-014115","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00168","article-title":"Novel and effective therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance","volume":"7","author":"Hu Y","year":"2017","unstructured":"Hu Y, Zhu Y, Lu NH. Novel and effective therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance. Front Cell Infect Microbiol. 2017, 7:168. 10.3389\/fcimb.2017.00168","journal-title":"Front Cell Infect Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05053.x","article-title":"Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures","volume":"35","author":"Gisbert JP","year":"2012","unstructured":"Gisbert JP, Castro-Fernandez M, Perez-Aisa A, et al.. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Aliment Pharmacol Ther. 2012, 35:941-7. 10.1111\/j.1365-2036.2012.05053.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","unstructured":"Notice to readers. updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. (2000). Accessed: February 28, 2025: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm4909a4.htm."},{"key":"ref9","unstructured":"Omeprazole + amoxicillin + rifabutin (TALICIA) criteria for use. (2024). Accessed. March 1, 2025: https:\/\/www.va.gov\/formularyadvisor\/DOC_PDF\/CFU_Omeprazole_amoxicillin_rifabutin_TALICIA_Nov_2024.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10010015","article-title":"Rifabutin for the treatment of Helicobacter pylori infection: a review","volume":"10","author":"Gisbert JP","year":"2020","unstructured":"Gisbert JP. Rifabutin for the treatment of Helicobacter pylori infection: a review. Pathogens. 2020, 10:15. 10.3390\/pathogens10010015","journal-title":"Pathogens"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/350284-idiosyncratic-drug-induced-neutropenia-following-pantoprazole-moxifloxacin-hydrochloride-and-rifabutin-treatment-for-helicobacter-pylori-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T22:05:08Z","timestamp":1756937108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/350284-idiosyncratic-drug-induced-neutropenia-following-pantoprazole-moxifloxacin-hydrochloride-and-rifabutin-treatment-for-helicobacter-pylori-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.91555","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}